Stereotactic body radiotherapy treatment of extracranial metastases

Nature Reviews Clinical Oncology

Volumn 9, Issue 11, 2012, Pages 654-665

  Salama, Joseph K ^a   Kirkpatrick, John P ^a   Yin, Fang Fang ^a  

^a DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IPILIMUMAB; SORAFENIB; SUNITINIB;

ACCURACY; ADRENAL METASTASIS; BLEEDING; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE FREE SURVIVAL; DYSPNEA; EDEMA; ELECTROMAGNETIC FIELD; EXTRACRANIAL METASTASIS; HUMAN; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MELANOMA; METASTASIS; METASTASIS POTENTIAL; MULTIPLE CYCLE TREATMENT; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT CARE PLANNING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION INJURY; RADIATION RESPONSE; RADIATION SAFETY; RADIOBIOLOGY; RADIOLOGICAL PARAMETERS; RADIOSENSITIVITY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINAL CORD METASTASIS; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; SURVIVAL TIME; THREE DIMENSIONAL IMAGING; TREATMENT INDICATION; TREATMENT RESPONSE;

HUMANS; NEOPLASM METASTASIS; NEOPLASMS; RADIOSURGERY;

EID: 84868194741     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2012.166     Document Type: Review

References (132)

1. Stetler-Stevenson, W. in Cancer Principles and Practice of Oncology 7th edn (eds DeVita, V. T., Hellman, S. & Rosenberg, S. A.) 113-127 (Lippincott Williams and Wilkins, Philadelphia, 2005
2. Connell, P. P. & Hellman, S. Advances in radiotherapy and implications for the next century: A historical perspective. Cancer Res. 69, 383-392 (2009
3. Mehta, N. et al. Analysis of further disease progression in metastatic non-small cell lung cancer: Implications for locoregional treatment. Int. J. Oncol. 25, 1677-1683 (2004
4. Rusthoven, K. E. et al. Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns of failure analysis. Acta Oncol. 48, 578-583 (2009
5. Hellman, S. & Weichselbaum, R. R. Oligometastases. J. Clin. Oncol. 13, 8-10 (1995
6. Weichselbaum, R. R. & Hellman, S. Oligometastases revisited. Nat. Rev. Clin. Oncol. 8, 378-382 (2011
7. Macdermed, D. M., Weichselbaum, R. R. & Salama, J. K. A rationale for the targeted treatment of oligometastases with radiotherapy. J. Surg. Oncol. 98, 202-206 (2008
8. The International Registry of Lung Metastases. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J. Thorac. Cardiovasc. Surg. 113, 37-49 (1997
9. Fong, Y. et al. Liver resection for colorectal metastases. J. Clin. Oncol. 15, 938-946 (1997
10. Tanvetyanon, T. et al. Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non small cell lung cancer: A systematic review and pooled analysis. J. Clin. Oncol. 26, 1142-1147 (2008
11. Wron'ski, M., Arbit, E., Burt, M. & Galicich, J. H. Survival after surgical treatment of brain metastases from lung cancer: A follow-up study of 231 patients treated between 1976 and 1991. J. Neurosurg. 83, 605-616 (1995
12. Miller, G. et al. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J. Am. Coll. Surg. 205, 231-238 (2007
13. Shah, S. A. et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J. Am. Coll. Surg. 202, 468-475 (2006
14. Blomgren, H., Lax, I., Näslund, I. & Svanström, R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 34, 861-870 (1995
15. Lax, I., Blomgren, H., Näslund, I. & Svanström, R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol. 33, 677-683 (1994
16. Timmerman, R. et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303, 1070-1076 (2010
17. Lee, M. T. et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J. Clin. Oncol. 27, 1585-1591 (2009
18. Milano, M. T., Katz, A. W., Zhang, H. & Okunieff, P. Oligometastases treated with stereotactic body radiotherapy: Long-term follow-up of prospective study. Int J. Radiat. Oncol. Biol. Phys. 83, 878-886 (2012
19. Rusthoven, K. E. et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J. Clin. Oncol. 27, 1579-1584 (2009
20. Rusthoven, K. E. et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J. Clin. Oncol. 27, 1572-1578 (2009
21. Salama, J. K. et al. Stereotactic body radiotherapy for multisite extracranial oligometastases: Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer 118, 2962-2970 (2012
22. Wang, X. S. et al. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: A phase 1-2 trial. Lancet Oncol. 13, 395-402 (2012
23. Chawla, S., Schell, M. C. & Milano, M. T. Stereotactic body radiation for the spine: A review. Am. J. Clin. Oncol. http://dx.doi.org/10.1097/COC. 0b013e31822dfd71.
24. Yamada, Y. et al. High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int. J. Radiat. Oncol. Biol. Phys. 71, 484-490 (2008
25. Regine, W. F. The radiation oncologist's perspective on stereotactic radiosurgery. Technol. Cancer Res. Treat. 1, 43-49 (2002
26. Niranjan, A. & Lunsford, L. D. Radiosurgery: where we were, are, and may be in the third millennium. Neurosurgery 46, 531-543 (2000
27. Benedict, S. H. et al. Stereotactic body radiation therapy: The report of AAPM Task Group 101. Med. Phys. 37, 4078-4101 (2012
28. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00922974 (2012
29. Chang, B. K. & Timmerman, R. D. Stereotactic body radiation therapy: A comprehensive review. Am. J. Clin. Oncol. 30, 637-644 (2007
30. Han, K. et al. A comparison of two immobilization systems for stereotactic body radiation therapy of lung tumors. Radiother. Oncol. 95, 103-108 (2010
31. Kupelian, P. et al. Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 67, 1088-1098 (2007
32. Ge, H., Cai, J., Kelsey, C. R. & Yin, F. Quantification and minimization of uncertainties of internal target volume (ITV) for stereotactic-body radiation therapy (SBRT) of lung cancer. Int. J. Radiat. Oncol. Biol. Phys. http://dx.doi.org/10.1016/j.ijrobp.2012.04.032.
33. Brock, K. K. Image registration in intensity-modulated, image-guided and stereotactic body radiation therapy. Front. Radiat. Ther. Oncol. 40, 94-115 (2007
34. Wu, Q. J. et al. Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra-and extracranial lesions. Radiat. Oncol. 4, 3 (2009
35. Wu, Q. J., Yoo, S., Kirkpatrick, J. P., Thongphiew, D. & Yin, F. F. Volumetric arc intensity-modulated therapy for spine body radiotherapy: Comparison with static intensity-modulated treatment. Int. J. Radiat. Oncol. Biol. Phys. 75, 1596-1604 (2009
36. Jin, J. Y., Yin, F. F., Ryu, S., Ajlouni, M. & Kim, J. H. Dosimetric study using different leaf-width MLCs for treatment planning of dynamic conformal arcs and intensity-modulated radiosurgery. Med. Phys. 32, 405-411 (2005
37. Jiang, S. B. et al. An experimental investigation on intra-fractional organ motion effects in lung IMRT treatments. Phys. Med. Biol. 48, 1773-1784 (2003
38. Tian, Y. et al. Dosimetric comparison of treatment plans based on free breathing, maximum, and average intensity projection CTs for lung cancer SBRT. Med. Phys. 39, 2754-2760 (2012
39. Solberg, T. et al. Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary. Pract. Radiat. Oncol. 2, 2-9 (2012
40. Roper, J. R., Bowsher, J. E., Wilson, J. M., Turkington, T. G. & Yin, F. F. Target localization using scanner-acquired SPECT data. J. Appl. Clin. Med. Phys. 10, 3724 (2012
41. Report of Task Group 104 of the Therapy Imaging Committee American Association of Physicists in Medicine. The Role of In-Room kV X Ray 933 Imaging for Patient Setup and Target Localization [online], http://www.aapm.org/pubs/ reports/RPT-104.pdf (2009
42. Barendsen, G. W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int. J. Radiat. Oncol. Biol. Phys. 8, 1981-1997 (1982
43. Dale, R. G. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br. J. Radiol. 58, 515-528 (1985
44. Douglas, B. G. & Fowler, J. F. The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation. Radiat. Res. 66, 401-426 (1976
45. Brenner, D. J. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin. Radiat. Oncol. 18, 234-239 (2008
46. Guerrero, M. & Li, X. A. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys. Med. Biol. 49, 4825-4835 (2004
47. Kirkpatrick, J. P., Brenner, D. J. & Orton, C. G. Point/Counterpoint. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Med. Phys. 36, 3381-3384 (2009
48. Kirkpatrick, J. P., Meyer, J. J. & Marks, L. B. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin. Radiat. Oncol. 18, 240-243 (2008
49. Park, C., Papiez, L., Zhang, S., Story, M. & Timmerman, R. D. Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 70, 847-852 (2008
50. Wang, J. Z., Huang, Z., Lo, S. S., Yuh, W. T. & Mayr, N. A. A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy. Sci. Transl. Med. 2, 39ra48 (2010
51. Garcia-Barros, M. et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300, 1155-1159 (2003
52. Fuks, Z. & Kolesnick, R. Engaging the vascular component of the tumor response. Cancer Cell 8, 89-91 (2005
53. Flickinger, J. C., Kondziolka, D., Maitz, A. H. & Lunsford, L. D. An analysis of the dose-response for arteriovenous malformation radiosurgery and other factors affecting obliteration. Radiother. Oncol. 63, 347-354 (2002
54. Flickinger, J. C. et al. Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group. Int. J. Radiat. Oncol. Biol. Phys. 46, 1143-1148 (2000
55. Levegrün, S., Hof, H., Essig, M., Schlegel, W. & Debus, J. Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: Dose/volume-response relations. Strahlenther. Onkol. 180, 758-767 (2004
56. Schneider, B. F., Eberhard, D. A. & Steiner, L. E. Histopathology of arteriovenous malformations after gamma knife radiosurgery. J. Neurosurg. 87, 352-357 (1997
57. Burnette, B. C. et al. The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity. Cancer Res. 71, 2488-2496 (2011
58. Katz, A. W. et al. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int. J. Radiat. Oncol. Biol. Phys. 67, 793-798 (2007
59. Okunieff, P. et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol. 45, 808-817 (2006
60. Chang, E. L. et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J. Neurosurg. Spine 7, 151-160 (2007
61. Chawla, S. et al. Stereotactic body radiotherapy for treatment of adrenal metastases. Int. J. Radiat. Oncol. Biol. Phys. 75, 71-75 (2009
62. Torok, J., Wegner, R. E., Burton, S. A. & Heron, D. E. Stereotactic body radiation therapy for adrenal metastases: A retrospective review of a noninvasive therapeutic strategy. Future Oncol. 7, 145-151 (2011
63. Kao, J. et al. Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: Acute toxicity and preliminary response. Cancer 115, 3571-3580 (2009
64. Corbin, K. et al. Feasibility and toxicity of hypofractionated image-guided radiotherapy for large volume limited metastatic disease practical radiation oncology. Pract. Radiat. Oncol. (in press
65. McCammon, R. et al. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 73, 112-118 (2009
66. Hasselle, M. D. et al. Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer. J. Thorac. Oncol. 7, 376-381 (2012
67. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00750269 (2012
68. Milano, M. T. et al. Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy. Radiother. Oncol. 91, 301-306 (2009
69. Goodman, K. A. et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int. J. Radiat. Oncol. Biol. Phys. 78, 486-493 (2010
70. Wulf, J. et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol. 45, 838-847 (2006
71. Wulf, J., Hädinger, U., Oppitz, U., Thiele, W. & Flentje, M. Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver. Radiother. Oncol. 66, 141-150 (2003
72. Herfarth, K. K. et al. Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int. J. Radiat. Oncol. Biol. Phys. 57, 444-451 (2003
73. Schefter, T. E. & Kavanagh, B. D. Radiation therapy for liver metastases. Semin. Radiat. Oncol. 21, 264-270 (2011
74. Olsen, C. C. et al. Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 73, 1414-1424 (2009
75. Stinauer, M. A., Diot, Q., Westerly, D. C., Schefter, T. E. & Kavanagh, B. D. Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases. Int. J. Radiat. Oncol. Biol. Phys. 83, e613-e618 (2012
76. Nelson, J. W. et al. Stereotactic body radiotherapy for lesions of the spine and paraspinal regions. Int. J. Radiat. Oncol. Biol. Phys. 73, 1369-1375 (2009
77. Ryu, S. et al. Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery. Cancer 109, 628-636 (2007
78. Sahgal, A., Larson, D. A. & Chang, E. L. Stereotactic body radiosurgery for spinal metastases: A critical review. Int. J. Radiat. Oncol. Biol. Phys. 71, 652-665 (2008
79. Masucci, G. L. et al. Stereotactic body radiotherapy is an effective treatment in reirradiating spinal metastases: Current status and practical considerations for safe practice. Expert Rev. Anticancer Ther. 11, 1923-1933 (2011
80. Yamada, Y. et al. Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: A preliminary report. Int. J. Radiat. Oncol. Biol. Phys. 62, 53-61 (2005
81. Teh, B. et al. The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT). Biomed. Imaging Interv. J. 3, e6 (2007
82. Hoyer, M. et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol. 45, 823-830 (2006
83. Salama, J. K. et al. An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin. Cancer Res. 14, 5255-5259 (2008)
84. Fuss, M. et al. Repositioning accuracy of a commercially available double-vacuum whole body immobilization system for stereotactic body radiation therapy. Technol. Cancer Res. Treat. 3, 59-67 (2004
85. Milano, M. T., Philip, A. & Okunieff, P. Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses. Int. J. Radiat. Oncol. Biol. Phys. 73, 832-837 (2009
86. Metcalfe, S. K. et al. Prospective trial of stereotactic body radiation therapy for colorectal oligometastases. Proc. Amer. Radium Soc. S059 (2010
87. Lussier, Y. A. et al. MicroRNA expression characterizes oligometastasis(es). PLoS One 6, e28650 (2011
88. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00892424 (2011
89. Cheruvu P. et al. Comparison of outcomes in patients with stage III versus oligometastatic stage IV non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 75 (Suppl.), S445 (2009
90. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00887315 (2012
91. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00776100 (2012
92. De Ruysscher, D. et al. Radical treatment of non-small cell lung cancer patients with synchronous oligometastases: Long-term results of a prospective phase II trial (NCT01282450). J. Thorac. Oncol. (in press
93. Milano, M. T., Zhang, H., Metcalfe, S. K., Muhs, A. G. & Okunieff, P. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res. Treat. 115, 601-608 (2009
94. van der Pool, A. E. et al. Stereotactic body radiation therapy for colorectal liver metastases. Br. J. Surg. 97, 377-382 (2010
95. Cheruvu, P. et al. Retrospective review of stereotactic body radiotherapy (SBRT) for lung metastases from colorectal cancer (CRC). Int. J. Radiat. Oncol. Biol. Phys. 78 (Suppl.), S316 (2010
96. Kim, M. S. et al. Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer. Oncology 76, 212-219 (2009
97. Kang, J. K. et al. Oligometastases confined one organ from colorectal cancer treated by SBRT. Clin. Exp. Metastasis 27, 273-278 (2010
98. Chang, D. T. et al. Stereotactic body radiotherapy for colorectal liver metastases: A pooled analysis. Cancer 117, 4060-4069 (2011
99. Engels, B. et al. Phase II study of helical tomotherapy for oligometastatic colorectal cancer. Ann. Oncol. 22, 362-368 (2011
100. Gerszten, P. C., Burton, S. A., Quinn, A. E., Agarwala, S. S. & Kirkwood, J. M. Radiosurgery for the treatment of spinal melanoma metastases. Stereotact. Funct. Neurosurg. 83, 213-221 (2005
101. Ranck, M. et al. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma. Am. J. Clin. Oncol. http://dx.doi.org/10. 1097/COC.0b013e31825d52b2.
102. Dhakal, S. et al. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: Excellent local lesion control and improved patient survival. Int. J. Radiat. Oncol. Biol. Phys. 82, 940-945 (2011
103. Kano, H. et al. Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases. Neurosurgery 69, 1232-1239 (2011
104. Liew, D. N. et al. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J. Neurosurg. 114, 769-779 (2011
105. Gerszten, P. C. et al. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J. Neurosurg. Spine 3, 288-295 (2005
106. Stinauer, M. A. et al. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: Impact of single fraction equivalent dose on local control. Radiat. Oncol. 6, 34 (2011
107. Wersäll, P. J. et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother. Oncol. 77, 88-95 (2005
108. Motzer, R. J. et al. Overall survival and updated results for sunitinib compared with interferon α in patients with metastatic renal cell carcinoma. J. Clin. Oncol. 27, 3584-3590 (2009
109. Escudier, B. et al. Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J. Clin. Oncol. 27, 3312-3318 (2009
110. Hudes, G. et al. Temsirolimus, interferon α, or both for advanced renal-cell carcinoma. N. Engl. J. Med. 356, 2271-2281 (2007
111. Ballo, M. T. et al. Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer 97, 1789-1796 (2003
112. Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711-723 (2010
113. Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD 1 antibody in cancer. N. Engl. J. Med. 366, 2443-2454 (2012
114. Seung, S. K. et al. Phase 1 study of stereotactic body radiotherapy and interleukin 2 - tumor and immunological responses. Sci. Transl. Med. 4, 137ra174 (2012
115. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01565837 (2012
116. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01557114 (2012
117. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01497808 (2011
118. Postow, M. A. et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N. Engl. J. Med. 366, 925-931 (2012
119. Zhang, B. et al. Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. J. Exp. Med. 204, 49-55 (2007
120. Cox, B. W., Jackson, A., Hunt, M., Bilsky, M. & Yamada, Y. Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 1, e661-667 (2012
121. Kong, F. M. et al. Consideration of dose limits for organs at risk of thoracic radiotherapy: Atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int. J. Radiat. Oncol. Biol. Phys. 81, 1442-1457 (2011
122. Timmerman, R. D. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin. Radiat. Oncol. 18, 215-222 (2008
123. Kavanagh, B. D. et al. Radiation dose-volume effects in the stomach and small bowel. Int. J. Radiat. Oncol. Biol. Phys. 76 (Suppl. 3), S101-S107 (2010
124. Pan, C. C. et al. Radiation-associated liver injury. Int. J. Radiat. Oncol. Biol. Phys. 76, S94-S100 (2010
125. Forquer, J. A. et al. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: Dose-limiting toxicity in apical tumor sites. Radiother. Oncol. 93, 408-413 (2009
126. Dunlap, N. E. et al. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 76, 796-801 (2010
127. Kirkpatrick, J. P., van der Kogel, A. J. & Schultheiss, T. E. Radiation dose-volume effects in the spinal cord. Int. J. Radiat. Oncol. Biol. Phys. 76 (Suppl. 3), S42-S49 (2010
128. Sahgal, A. et al. Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int. J. Radiat. Oncol. Biol. Phys. http://dx.doi.org/10.1016/j.ijrobp.2012.05.007.
129. Sahgal, A. et al. Spinal cord tolerance for stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 77, 548-553 (2010
130. Wulf, J., Baier, K., Mueller, G. & Flentje, M. P. Dose-response in stereotactic irradiation of lung tumors. Radiother. Oncol. 77, 83-87 (2005
131. Gibbs, I. C. et al. Image-guided robotic radiosurgery for spinal metastases. Radiother. Oncol. 82, 185-190 (2007
132. Cheruvu, P. et al. Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer. Radiat. Oncol. 6, 80 (2011